Related Experiment Videos
Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and
M Hayashi1, M E Dorf, S Abromson-Leeman
1Harvard Medical School, Department of Pathology, Boston, MA 02115.
Abstract:
Granulocyte-macrophage colony stimulating factor (GM-CSF) modulates various functions of monocytes/macrophages including antigen-presenting capacity. Recently it was found that astrocytes produce GM-CSF in the central nervous system (CNS) and that GM-CSF can induce proliferation and morphological changes of microglia. Here we show that GM-CSF can down regulate the interferon-gamma-mediated induction of major histocompatibility complex (MHC) class II antigens in microglia, but not in astrocytes. GM-CSF pretreatment completely prevents myelin basic protein-specific T cell proliferation induced by microglia not astrocytes. GM-CSF did not affect the cell surface expression on microglia of either MHC class I or cell adhesion molecules. The inhibition of microglial MHC class II expression and antigen-presenting function is specific for GM-CSF, as treatment with a different CSF (interleukin-3) did not modulate microglial phenotype or functional capacity. These data suggest that GM-CSF might be involved in the regulation of immune responses within the central nervous system.
Insights
Granulocyte-macrophage colony-stimulating factor (GM-CSF) regulates microglia function in the central nervous system. GM-CSF inhibits major histocompatibility complex class II expression and antigen presentation by microglia.
Area of Science:
- Neuroimmunology
- Cellular immunology
Background:
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) influences monocyte/macrophage functions, including antigen presentation.
- Astrocytes in the central nervous system (CNS) produce GM-CSF, affecting microglia proliferation and morphology.
Purpose of the Study:
- To investigate the effect of GM-CSF on microglial antigen-presenting capacity and phenotype.
- To determine GM-CSF's role in regulating immune responses within the CNS.
Main Methods:
- Treatment of microglia and astrocytes with GM-CSF.
- Assessment of major histocompatibility complex (MHC) class II antigen expression via flow cytometry.
- Evaluation of T cell proliferation assays using myelin basic protein-specific T cells.
Main Results:
- GM-CSF down-regulated interferon-gamma-induced MHC class II expression in microglia, but not astrocytes.
- GM-CSF pretreatment inhibited microglia-mediated T cell proliferation.
- GM-CSF did not alter MHC class I or cell adhesion molecule expression on microglia.
- Interleukin-3, another CSF, did not affect microglial phenotype or function.
Conclusions:
- GM-CSF plays a specific role in modulating microglial antigen-presenting function within the CNS.
- GM-CSF may be a key regulator of neuroinflammatory and immune responses.